The KEGG enrichment analysis suggested these drugs mainly work through multiple pathways in pathways in cancer, endocrine resistance, human cytomegalovirus infection, EGFR tyrosine kinase inhibitor resistance, proteoglycans in cancer. This evidence concerns the gene EGFR and cytomegalovirus infection.